rs1368531129
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BP7
This summary comes from the ClinGen Evidence Repository: BP4Multiple lines of computational evidence suggest no impact on gene /gene product. BP4: This synonymous variant has a SpliceAI Δ score < 0.2 and PhyloP100way: 1.191BP7Silent variant predicted with no splice impact. BP7: Evolutionary conservation prediction algorithms predict the site as not being conserved(PhyloP score < 2.0) (BP7).In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteriaapplied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1:BP4, BP7 LINK:https://erepo.genome.network/evrepo/ui/classification/CA512318849/MONDO:0100083/008
Frequency
Consequence
NM_001754.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUNX1 | NM_001754.5 | c.294C>T | p.Leu98= | synonymous_variant | 4/9 | ENST00000675419.1 | NP_001745.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUNX1 | ENST00000675419.1 | c.294C>T | p.Leu98= | synonymous_variant | 4/9 | NM_001754.5 | ENSP00000501943 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461310Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727002
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2023 | - - |
Likely benign, reviewed by expert panel | curation | ClinGen Myeloid Malignancy Variant Curation Expert Panel | Nov 13, 2023 | BP4 Multiple lines of computational evidence suggest no impact on gene /gene product. BP4: This synonymous variant has a SpliceAI Δ score < 0.2 and PhyloP100way: 1.191 BP7 Silent variant predicted with no splice impact. BP7: Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score < 2.0) (BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at